Delivery Order SPE2DH22D0002-SPE2D424F856E

Award Date 6/27/24
Potential Completion Date 7/5/24
Potential Value $9.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78727, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,800.00 firm fixed price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract is for the ARIES C.DIFFICILE ASSAY, with a completion date of February 22, 2024. No set-aside was used for this award. Luminex provides multiplex diagnostic solutions, assay kits, and related products to federal agencies including the Centers for Disease Control and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Luminex Corp, a manufacturer of biological testing technologies. The $9,600 contract is for the delivery of Aries C. Difficile Assay test kits. This order is not associated with a set-aside program and is scheduled to be completed by July 11, 2024. Luminex has previously received prime contracts, subcontracts, and subawards from various federal agencies, including the Centers for Disease Control and...
Luminex Corporation was awarded a $960 firm fixed price delivery order against an unspecified government-wide acquisition contract (GWAC) by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to provide an ARIES C.DIFFICILE ASSAY. The delivery order has a period of performance through May 3, 2023 for the assay, which is used to detect Clostridium difficile, and has no set-aside designation. Luminex Corporation will perform the work as the prime contractor in Austin,...
This federal contract award, SPE2DH22D0002|SPE2D422F29A1, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Luminex Corp, a manufacturer of biological testing technologies. The $95,000.00 firm fixed price delivery order is for ARIES M12V1 SYSTEM IVD, a diagnostic equipment product line. This award was made on an unrestricted, full and open competition basis. As a prime contractor, Luminex has previously delivered specialized multiplexing systems, assay...
Luminex Corporation, a manufacturer of biological testing technologies, has been awarded a $4,800 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical for an ARIES C.DIFFICILE ASSAY. This task order was issued against an existing Luminex blanket purchase agreement and will provide C. difficile diagnostic testing products to support the agency's medical supply and laboratory programs. Luminex will deliver its proprietary ARIES assay kits from its Austin, Texas...
This is a firm fixed-price delivery order awarded to Luminex Corp, a foreign-owned, for-profit manufacturer of diagnostic technologies, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The $2,359.50 contract is for the provision of "LUMINEX 100/200 PERFORMANCE VERIFICATION" services, which involves the delivery of specialized diagnostic equipment and maintenance for the agency's medical testing capabilities. Luminex has several existing indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies. The $7,150.00 order is for the provision of Luminex's 100/200 testing platform, which supports automated analysis of multiple biomarkers. This award falls under a larger indefinite delivery vehicle and is not set-aside. Luminex has a history of providing multiplex diagnostic solutions, assay kits, reagents,...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a manufacturer of biological testing technologies. The contract is for the provision of 1 milliliter of MAGPLEX microspheres, which are used in multiplex diagnostic solutions. The total ceiling value of the contract is $7,905.60, and the period of performance extends to April 16, 2024. The contract was not set aside for any specific business size or type. Luminex has provided various...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a manufacturer of biological testing technologies. The contract is for the procurement of 4,565,284,972 MAGPLEX-AVIDIN MICROSPHERES, 1 ML, with a ceiling value of $2,592.00 and a period of performance through August 1, 2024. The contract does not have a set-aside designation. Luminex, which is a foreign-owned, for-profit manufacturer, has provided various diagnostic testing products,...
This is a delivery order contract awarded to Luminex Corp, a foreign-owned, for-profit manufacturer of diagnostic technologies, by the Defense agency's Medical Supply Chain. The contract is for $3,685.00 and has a period of performance through February 10, 2025. It is a firm fixed-price contract for the provision of LUMINEX 100/200 Performance Verification products and services. This contract was awarded without any small business set-aside designation. Luminex Corp has also been awarded other...
  • SPE2DH22D0002
    Indefinite Delivery Contract
  • SPE2DH22D0002-SPE2D424F856E
    Delivery Order

This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Luminex Corporation, a manufacturer of biological testing technologies. The contract is for the delivery of 4565019901 ARIES C. DIFFICILE ASSAY, a diagnostic testing product, with a ceiling value of $9,600.00 and a performance period ending on July 5, 2024. Luminex is a foreign-owned, for-profit organization that has been awarded other federal contracts and subcontracts, including supporting clinical testing programs and biomedical research efforts across various government agencies. This delivery order is not associated with a set-aside designation.

Generated 9/26/24, 9:11 AM